blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2149565

EP2149565 - Sulfoximine substituted chinazoline derivatives as immune modulators for the treatment of inflammatory and allergic diseases [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  25.02.2011
Database last updated on 23.04.2024
Most recent event   Tooltip25.02.2011Application deemed to be withdrawnpublished on 30.03.2011  [2011/13]
Applicant(s)For all designated states
Bayer Schering Pharma Aktiengesellschaft
Müllerstrasse 170-178
13353 Berlin / DE
[2010/05]
Inventor(s)01 / Nguyen, Duy, Dr.
Heinrich-Heine-Str. 27
10179 Berlin / DE
02 / Buchmann, Bernd, Dr.
Erdmannstr. 44
16540 Hohen Neuendorf / DE
03 / Kosemund, Dirk, Dr.
Frierich-Engels-Strasse 58
07745 Jena / DE
04 / Von Bonin, Arne, Dr.
Rosa-Luxemburg-Strasse 6a
16548 Glienicke-Nordbahn / DE
 [2010/05]
Representative(s)Bergmann, Martina
Müllerstrasse 178
13353 Berlin / DE
[N/P]
Former [2010/05]Bergmann, Martina
Müllerstrasse 178
13353 Berlin / DE
Application number, filing date08075664.624.07.2008
[2010/05]
Filing languageDE
Procedural languageDE
PublicationType: A1 Application with search report 
No.:EP2149565
Date:03.02.2010
Language:DE
[2010/05]
Search report(s)(Supplementary) European search report - dispatched on:EP16.02.2009
ClassificationIPC:C07D239/94, A61K31/517, A61P37/02, A61P37/08
[2010/05]
CPC:
C07D239/94 (EP,US); A61P19/02 (EP); A61P29/00 (EP);
A61P35/00 (EP); A61P37/00 (EP); A61P37/02 (EP);
A61P37/08 (EP) (-)
Designated contracting states(deleted) [2010/40]
Former [2010/05]AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MT,  NL,  NO,  PL,  PT,  RO,  SE,  SI,  SK,  TR 
TitleGerman:Sulfonsubstituierte Chinazolinderivate als Immunmodulatoren zur Behandlung von enzündlichen und allergischen Erkrankungen[2010/05]
English:Sulfoximine substituted chinazoline derivatives as immune modulators for the treatment of inflammatory and allergic diseases[2010/05]
French:Dérivés de chinazoline substitués par du sulfonamide en tant que modulateurs d'immunité pour le traitement de inflammations et allergies[2010/05]
Examination procedure04.08.2010Application deemed to be withdrawn, date of legal effect  [2011/13]
21.09.2010Despatch of communication that the application is deemed to be withdrawn, reason: examination fee not paid in time  [2011/13]
Fees paidPenalty fee
Additional fee for renewal fee
31.07.201003   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[X]WO0047212  (ASTRAZENECA UK LTD [GB], et al) [X] 1-14,16-18 * page 2, line 19 * * page 128 - page 130; examples 50-52 * * page 150; example 83 * * page 156; example 106 * * page 211 - page 212; examples 185-188 * * page 271; example 263 *;
 [X]WO0121596  (ASTRAZENECA AB [SE], et al) [X] 1-14,16-18 * page 1, paragraph 1 * * page 41; table 8; compound 213 *;
 [A]WO2005007672  (COLEY PHARM GMBH [DE], et al) [A] 1-18 * page 1, paragraph 1 * * page 70 - page 71; table 3; compound - * * page 73 - page 75; table 4; compound - * * page 106 - page 111; examples 8,10,11 * * page 119 - page 129; examples 19-28 ** claims 31-35,113,125,128,133,138 *
by applicantWO9317682
 WO2004058752
 US2005222175
 WO2006076246
    - GEMÄß Y. HANG ET AL., ORG. LETT., (2004), vol. 6, pages 4775 - 4778
    - HOUBEN-WEYL, Methods of Molecular Transformations, THIEME VERLAG, (2004), vol. 16, pages 573 - 749
    - 0. MITSUNOBU, SYNTHESIS, (1981), pages 1 - 27
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.